|
|
[资源]
The Medicine Maker - February 2019+The Pathologist - February 2019
The development of new drugs and biological medicines draws on the talent, passion and experience of a wide range of professionals. The goal of The Medicine Maker is to integrate all aspects of the process, from the registration of an Investigational New Drug (IND) or Biologics License Application (BLA) through to the market launch of new therapies, and beyond.
The Medicine Maker combines topical news coverage with practical, pragmatic articles that are meaningful to the daily working life of experts in the clinical, regulatory, development and manufacturing fields. Feature articles tell the stories behind the biggest concepts, issues and advances in the field, and departments will cover topics in business, policy to advice and career development.![The Medicine Maker - February 2019+The Pathologist - February 2019]()
e2dc88b322.png
![The Medicine Maker - February 2019+The Pathologist - February 2019-1]()
e0a88eb819.png |
» 本帖附件资源列表
» 猜你喜欢
售SCI一区T0P文章,我:8.O.55.1.O.54,科目齐全,可+急
已经有4人回复
售SCI文章,我:8O.5.5.1O.54,科目全,可十急
已经有4人回复
售SCI一区T0P文章,我:8O.55.1.O.54,科目全,可伽急
已经有4人回复
售SCI一区T0P文章,我:8.O.55.1.O54,科目全,可伽急
已经有4人回复
售SCI一区文章,我:8O5.5.1.O5.4,科目全,可伽急
已经有6人回复
售SCI一区文章,我:8O5.5.1.O5.4,科目全,可伽急
已经有6人回复
售一区SCI文章T0P,我:8O.551.O54,科目全,可十急
已经有4人回复
某top大学教授说“能够在市场中兑现的能力才是真能力”无比同意!
已经有13人回复
同一个分子,一条来自文献,一条来自AI——不告诉你答案,你会选哪条?
已经有7人回复
售SCI文章,我:8O.5.5.1O.54,科目全,可十急
已经有4人回复
|